Unwin David, Khalid Ali Ahsan, Unwin Jen, Crocombe Dominic, Delon Christine, Martyn Kathy, Golubic Rajna, Ray Sumantra
Norwood Surgery, Southport, Merseyside, UK.
NNEdPro Global Centre for Nutrition and Health, St John's Innovation Centre, Cambridge, Cambridgeshire, UK.
BMJ Nutr Prev Health. 2020 Nov 2;3(2):285-294. doi: 10.1136/bmjnph-2020-000072. eCollection 2020 Dec.
In a single general practice (GP) surgery in England, there was an eightfold increase in the prevalence of type 2 diabetes (T2D) in three decades with 57 cases and 472 cases recorded in 1987 and 2018, respectively. This mirrors the growing burden of T2D on the health of populations round the world along with healthcare funding and provision more broadly. Emerging evidence suggests beneficial effects of carbohydrate-restricted diets on glycaemic control in T2D, but its impact in a 'real-world' primary care setting has not been fully evaluated.
Advice on a lower carbohydrate diet was offered routinely to patients with newly diagnosed and pre-existing T2D or prediabetes between 2013 and 2019, in the Norwood GP practice with 9800 patients. Conventional 'one-to-one' GP consultations were used, supplemented by group consultations, to help patients better understand the glycaemic consequences of their dietary choices with a particular focus on sugar, carbohydrates and foods with a higher Glycaemic Index. Those interested were computer coded for ongoing audit to compare 'baseline' with 'latest follow-up' for relevant parameters.
By 2019, 128 (27%) of the practice population with T2D and 71 people with prediabetes had opted to follow a lower carbohydrate diet for a mean duration of 23 months. For patients with T2D, the median (IQR) weight dropped from of 99.7 (86.2, 109.3) kg to 91.4 (79, 101.1) kg, p<0.001, while the median (IQR) HbA1c dropped from 65.5 (55, 82) mmol/mol to 48 (43, 55) mmol/mol, p<0.001. For patients with prediabetes, the median (IQR) HbA1c dropped from 44 (43, 45) mmol/mol to 39 (38, 41) mmol/mol, p<0.001. Drug-free T2D remission occurred in 46% of participants. In patients with prediabetes, 93% attained a normal HbA1c. Since 2015, there has been a relative reduction in practice prescribing of drugs for diabetes leading to a T2D prescribing budget £50 885 per year less than average for the area.
This approach to lower carbohydrate dietary advice for patients with T2D and prediabetes was incorporated successfully into routine primary care over 6 years. There were statistically significant improvements in both groups for weight, HbA1c, lipid profiles and blood pressure as well as significant drug budget savings. These results suggest a need for more empirical research on the effects of lower carbohydrate diet and long-term glycaemic control while recording collateral impacts to other metabolic health outcomes.
在英格兰的一家普通全科诊所,2型糖尿病(T2D)的患病率在三十年中增长了八倍,1987年和2018年分别记录了57例和472例。这反映出T2D对全球人口健康以及更广泛的医疗保健资金和服务的负担日益加重。新出现的证据表明,低碳水化合物饮食对T2D患者的血糖控制有益,但尚未在“现实世界”的初级保健环境中对其影响进行全面评估。
2013年至2019年期间,在拥有9800名患者的诺伍德全科诊所,对新诊断和已患T2D或糖尿病前期的患者常规提供低碳水化合物饮食建议。采用传统的“一对一”全科医生咨询,并辅以小组咨询,以帮助患者更好地理解其饮食选择对血糖的影响,特别关注糖、碳水化合物和血糖生成指数较高的食物。感兴趣的患者进行计算机编码以便持续审计,以比较相关参数的“基线”与“最新随访”情况。
到2019年,该诊所128名(27%)T2D患者和71名糖尿病前期患者选择遵循低碳水化合物饮食,平均持续时间为23个月。对于T2D患者,体重中位数(四分位间距)从99.7(86.2,109.3)kg降至91.4(79,101.1)kg,p<0.001,而糖化血红蛋白(HbA1c)中位数(四分位间距)从65.5(55,82)mmol/mol降至48(43,55)mmol/mol,p<0.001。对于糖尿病前期患者,HbA1c中位数(四分位间距)从44(43,45)mmol/mol降至39(38,41)mmol/mol,p<0.001。46%的参与者实现了无药缓解T2D。在糖尿病前期患者中,93%的患者HbA1c恢复正常。自2015年以来,该诊所糖尿病药物处方相对减少,导致T2D处方预算比该地区平均水平每年少50885英镑。
这种为T2D和糖尿病前期患者提供低碳水化合物饮食建议的方法在6年多的时间里成功纳入了常规初级保健。两组患者的体重、HbA1c、血脂谱和血压均有统计学意义上的显著改善,同时药物预算也大幅节省。这些结果表明,需要对低碳水化合物饮食的影响和长期血糖控制进行更多实证研究,同时记录对其他代谢健康结果的附带影响。